Odgren Lab Publications
Title
NHA-oc/NHA2: a mitochondrial cation-proton antiporter selectively expressed in osteoclasts
UMMS Affiliation
Department of Cell Biology
Publication Date
1-9-2008
Document Type
Article
Subjects
Amino Acid Sequence; Animals; Antiporters; Caspases; Cell Differentiation; Cell Line; Cloning, Molecular; Enzyme Activation; Gene Expression Regulation; Humans; Hydrogen-Ion Concentration; Mice; Mitochondria; Mitochondrial Swelling; Molecular Sequence Data; Osteoclasts; RNA, Messenger; RNA, Small Interfering
Disciplines
Cell Biology
Abstract
Bone resorption is regulated by a complex system of hormones and cytokines that cause osteoblasts/stromal cells and lymphocytes to produce factors including RANKL, that ultimately result in the differentiation and activation of osteoclasts, the bone resorbing cells. We used a microarray approach to identify genes upregulated in RANKL-stimulated osteoclast precursor cells. Osteoclast expression was confirmed by multiple tissue Northern and in situ hybridization analysis. Gene function studies were carried out by siRNA analysis. We identified a novel gene, which we termed nha-oc/NHA2, which is strongly upregulated during RANKL-induced osteoclast differentiation in vitro and in vivo. nha-oc/NHA2 encodes a novel cation-proton antiporter (CPA) and is the mouse orthologue of a human gene identified in a database search: HsNHA2. nha-oc/NHA2 is selectively expressed in osteoclasts. NHA-oc/NHA2 protein localizes to the mitochondria, where it mediates Na(+)-dependent changes in mitochondrial pH and Na(+) acetate induced mitochondrial passive swelling. RNA silencing of nha-oc/nha2 reduces osteoclast differentiation and resorption, suggesting a role for NHA-oc/NHA2 in these processes. nha-oc/NHA2 therefore is a novel member of the CPA family and is the first mitochondrial NHA characterized to date. nha-oc/NHA2 is also unique in that it is the first eukaryotic and tissue-specific CPA2 characterized to date. NHA-oc/NHA2 displays the expected activities of a bona fide CPA and plays a key role(s) in normal osteoclast differentiation and function.
DOI of Published Version
10.1016/j.bone.2007.09.046
Source
Bone. 2008 Jan;42(1):180-92. Epub 2007 Sep 26. Link to article on publisher's site
Journal/Book/Conference Title
Bone
Related Resources
PubMed ID
17988971
Repository Citation
Battaglino, Ricardo A.; Pham, L.; Morse, Leslie R.; Vokes, M.; Sharma, A.; Odgren, Paul R.; Yang, Meilheng; Sasaki, Hajime; and Stashenko, Philip, "NHA-oc/NHA2: a mitochondrial cation-proton antiporter selectively expressed in osteoclasts" (2008). Odgren Lab Publications. 6.
https://escholarship.umassmed.edu/odgren/6